Showing results (11-20 of 109) with videos related to
Sort By:
Pageof 11
International Journal of Molecular Sciences|August 26, 2023
Immune Checkpoint Inhibitors in "Special" NSCLC Populations: A Viable Approach?Giuseppe Bronte, Donato Michele Cosi, Chiara Magri, et al.Current Cancer Drug Targets|January 22, 2010
Bortezomib: a new pro-apoptotic agent in cancer treatmentAntonio Russo, Giuseppe Bronte, Fabio Fulfaro, et al.Cancers|April 12, 2020
Fully Human Antibodies for Malignant Pleural Mesothelioma TargetingFabio Nicolini, Martine Bocchini, Davide Angeli, et al.Pharmacology & Therapeutics|July 3, 2018
Cardiotoxicity mechanisms of the combination of BRAF-inhibitors and MEK-inhibitorsEnrico Bronte, Giuseppe Bronte, Giuseppina Novo, et al.Anticancer Research|February 9, 2013
Lenograstim in preventing chemotherapy-induced febrile neutropenia in patients with soft tissue sarcomaGiuseppe Badalamenti, Lorena Incorvaia, Salvatore Provenzano, et al.Breast Cancer (Dove Medical Press)|December 25, 2013
HER2-positive male breast cancer: an updateLaura Ottini, Carlo Capalbo, Piera Rizzolo, et al.Translational Lung Cancer Research|December 21, 2019
Role of liquid biopsy in oncogene-addicted non-small cell lung cancerMatteo Canale, Luigi Pasini, Giuseppe Bronte, et al.Frontiers in Oncology|February 11, 2020
Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the FutureFabio Nicolini, Martine Bocchini, Giuseppe Bronte, et al.Expert Opinion on Emerging Drugs|January 28, 2010
Anti-endothelin drugs in solid tumorsAntonio Russo, Giuseppe Bronte, Sergio Rizzo, et al.Biological Reviews of the Cambridge Philosophical Society|April 20, 2018
Epithelial-to-mesenchymal transition in the context of epidermal growth factor receptor inhibition in non-small-cell lung cancerGiuseppe Bronte, Sara Bravaccini, Enrico Bronte, et al.Pageof 11